🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Clinical Study of Intraocular Lens Injectors Lioli™, Pioli™, and Pioli™ Plus

Recruitingn/aAges 40 Years - anyAllAST Products, Inc.
NCT07140029 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate whether different intraocular lens (IOL) injectors affect surgical outcomes in patients aged 40 and older undergoing cataract surgery. The main questions it aims to answer are: * Do different IOL injectors change the size of the corneal incision during surgery? * Do the injectors lead to different rates of complications during or after surgery? Researchers will compare the use of three different IOL injectors: two preloaded models (pioli™ and pioli™ Plus) and one manually loaded model (lioli™), to see if the preloaded systems improve surgical results compared to the manual one. Participants will: * Undergo routine cataract surgery using one of the three injectors, randomly assigned. * Have measurements taken before and after surgery (e.g., vision tests, corneal incision size). * Be monitored for any side effects or complications duri

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 40 years or older * Scheduled for cataract surgery using phacoemulsification technique * Planned implantation of an Asqelio™ monofocal intraocular lens (IOL) * Clear intraocular media, except for the presence of cataract (i.e., no other significant ocular opacities) Exclusion Criteria: * Preoperative corneal astigmatism \> 1.0 diopter (D) * Previous corneal surgery or history of ocular trauma * Irregular cornea (e.g., keratoconus) * Choroidal hemorrhage * Microphthalmos * Severe corneal dystrophy * Uncontrolled or medically controlled glaucoma * Clinically significant macular changes * Severe concomitant ocular disease * Cataract not related to aging * Severe optic nerve atrophy * Diabetic retinopathy * Proliferative diabetic retinopathy * Amblyopia * Extremely shallow anterior chamber * Severe chronic uveitis * Pregnant or breastfeeding * Rubella * Mature or dense cataracts that prevent preoperative retinal examination * History of retinal detachment * Concurrent participation in another drug or medical device clinical study
💊

What it tests

  • Not listed
📍

Where

1 site
Clínica OftalVist Sevilla
Seville, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy